COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    A3L35
Previous Study | Return to List | Next Study

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02428491
Recruitment Status : Completed
First Posted : April 28, 2015
Last Update Posted : June 1, 2018
Information provided by (Responsible Party):
Sanofi ( Sanofi Pasteur, a Sanofi Company )

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 11, 2017
Actual Study Completion Date : January 11, 2017